<DOC>
	<DOCNO>NCT00769782</DOCNO>
	<brief_summary>RATIONALE : Surgery may effective treatment liver metastasis gastrointestinal stromal tumor . PURPOSE : This phase II trial study well surgery work treat patient liver metastasis gastrointestinal stromal tumor .</brief_summary>
	<brief_title>Surgery Treating Patients With Liver Metastasis From Gastrointestinal Stromal Tumor</brief_title>
	<detailed_description>OBJECTIVES : - To evaluate safety efficacy surgery patient resectable hepatic metastasis secondary gastrointestinal stromal tumor . OUTLINE : This multicenter study . Patients undergo surgical resection hepatic metastasis .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Gastrointestinal Stromal Tumors</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis gastrointestinal stromal tumor ( GIST ) Hepatic metastasis meeting follow criterion : Clinically diagnose surgically resectable macroscopic residual tumor No 3 hepatic metastasis Synchronous hepatic metastasis allow provided primary tumor also resectable Does require radiofrequency ablation and/or microwave coagulation therapy control disease No extrahepatic metastasis No history GIST recurrence PATIENT CHARACTERISTICS : ECOG performance status 01 Leukocyte count ≥ 3,000/μL Neutrophil count ≥ 1,500/μL Hemoglobin ≥ 8.0 g/dL Platelet count ≥ 75,000/μL Total bilirubin ≤ 2.0 mg/dL ALT AST &lt; 120 IU/L GTP &lt; 210 IU/L Not pregnant No poorly control diabetes mellitus No NYHA class IIIIV cardiac function No hepatitis B hepatitis B carriers No malignancy require treatment PRIOR CONCURRENT THERAPY : See Disease Characteristics No prior interventional radiology metastatic disease No prior concurrent imatinib mesylate No concurrent treatment</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>gastrointestinal stromal tumor</keyword>
	<keyword>liver metastasis</keyword>
</DOC>